Kidney and cardiac biomarkers and risk of adverse kidney outcomes in patients with type 2 diabetes and kidney disease, cardiovascular disease, or both

被引：0
|
作者：
Mc Causland, Finnian
Claggett, Brian
Solomon, Scott
Chaturvedi, Nishi
de Zeeuw, Dick
Malachias, Marcus
McGrath, Martina
McMurray, John
Neuen, Brendon
Vaduganathan, Muthiah
机构：
来源：
CIRCULATION | 2024年 / 150卷
关键词：
D O I：
10.1161/circ.150.suppl_1.4141918
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4141918
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Kidney function and the risk of cardiovascular disease in patients with type 2 diabetes
    Wang, Yujie
    Katzmarzyk, Peter T.
    Horswell, Ronald
    Zhao, Wenhui
    Johnson, Jolene
    Hu, Gang
    KIDNEY INTERNATIONAL, 2014, 85 (05) : 1192 - 1199
  • [2] Finerenone and Cardiovascular Outcomes in Patients With Chronic Kidney Disease and Type 2 Diabetes
    Filippatos, Gerasimos
    Anker, Stefan D.
    Agarwal, Rajiv
    Pitt, Bertram
    Rossing, Peter
    Ruilope, Luis M.
    Kolkhof, Peter
    Schloemer, Patrick
    Tornus, Ingo
    Joseph, Amer
    Bakris, George L.
    CIRCULATION, 2020, 142 (24) : E470 - E470
  • [3] Finerenone and Cardiovascular Outcomes in Patients With Chronic Kidney Disease and Type 2 Diabetes
    Filippatos, Gerasimos
    Anker, Stefan D.
    Agarwal, Rajiv
    Pitt, Bertram
    Ruilope, Luis M.
    Rossing, Peter
    Kolkhof, Peter
    Schloemer, Patrick
    Tornus, Ingo
    Joseph, Amer
    Bakris, George L.
    CIRCULATION, 2021, 143 (06) : 540 - 552
  • [4] Cardiovascular and kidney outcomes with finerenone in patients with type 2 diabetes and chronic kidney disease: the FIDELITY pooled analysis
    Agarwal, Rajiv
    Filippatos, Gerasimos
    Pitt, Bertram
    Anker, Stefan D.
    Rossing, Peter
    Joseph, Amer
    Kolkhof, Peter
    Nowack, Christina
    Gebel, Martin
    Ruilope, Luis M.
    Bakris, George L.
    EUROPEAN HEART JOURNAL, 2022, 43 (06) : 474 - +
  • [5] Biomarkers Determining Cardiovascular Risk in Patients with Kidney Disease
    Siasos, G.
    Tousoulis, D.
    Michalea, S.
    Oikonomou, E.
    Kolia, C.
    Kioufis, S.
    Synetos, A.
    Vlasis, K.
    Papavassiliou, A. G.
    Stefanadis, C.
    CURRENT MEDICINAL CHEMISTRY, 2012, 19 (16) : 2555 - 2571
  • [6] Diabetes, Cardiovascular Disease, and Cardiovascular Risk in Patients with Chronic Kidney Disease
    De Lima, Jose J. G.
    Gowdak, Luis Henrique W.
    David-Neto, Elias
    Bortolotto, Luiz A.
    HIGH BLOOD PRESSURE & CARDIOVASCULAR PREVENTION, 2021, 28 (02) : 159 - 165
  • [7] Diabetes, Cardiovascular Disease, and Cardiovascular Risk in Patients with Chronic Kidney Disease
    Jose J. G. De Lima
    Luis Henrique W. Gowdak
    Elias David-Neto
    Luiz A. Bortolotto
    High Blood Pressure & Cardiovascular Prevention, 2021, 28 : 159 - 165
  • [8] Hematocrit, independent of chronic kidney disease, predicts adverse cardiovascular outcomes in Chinese patients with type 2 diabetes
    Tong, Peter C. Y.
    Kong, Alice P. S.
    So, Wing-Yee
    Ng, Margaret H. L.
    Yang, Xilin
    Ng, Maggie C. Y.
    Ma, Ronald C. W.
    Ho, Chung-Shun
    Lam, Christopher W. K.
    Chow, Chun-Chung
    Cockram, Clive S.
    Chan, Juliana C. N.
    DIABETES CARE, 2006, 29 (11) : 2439 - 2444
  • [9] Type 2 diabetes doubles cardiac disease risk in chronic kidney disease
    不详
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 2018, 79 (07) : 370 - 370
  • [10] In patients with type 2 diabetes chronic kidney disease is a modifiable cardiovascular risk factor
    Agarwal, R.
    Pitt, B.
    Rossing, P.
    Anker, S. D.
    Filippatos, G.
    Ruilope, L. M.
    Kovesdy, C. P.
    Tuttle, K.
    Vaduganathan, M.
    Wanner, C.
    Bansilal, S.
    Gebel, M.
    Joseph, A.
    Lawatscheck, R.
    Bakris, G.
    EUROPEAN HEART JOURNAL, 2022, 43 : 2420 - 2420
12345